Publication: Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
Program
KU-Authors
KU Authors
Co-Authors
Etzion, Ohad
Hamid, Saeed Sadiq
Asselah, Tarik
Gherlan, George Sebastian
Turcanu, Adela
Petrivna, Tsarynna
Weissfeld, Lisa
Choong, Ingrid
Hislop, Colin
Apelian, David
Publication Date
Language
Type
Embargo Status
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Subject
Gastroenterology and hepatology
Citation
Has Part
Source
Journal of Hepatology